ISRG - Intuitive Surgical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
568.7100
+11.9400 (+2.14%)
As of 3:08PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close556.7700
Open556.3600
Bid568.5600 x 1800
Ask568.8500 x 800
Day's Range553.0770 - 568.7850
52 Week Range337.7967 - 572.9600
Volume263,383
Avg. Volume640,864
Market Cap64.69B
Beta1.11
PE Ratio (TTM)83.87
EPS (TTM)6.7810
Earnings DateOct 17, 2018 - Oct 22, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est569.80
Trade prices are not sourced from all markets
  • Intuitive Surgical and InTouch Collaborate for IoMT Services
    Zacks5 hours ago

    Intuitive Surgical and InTouch Collaborate for IoMT Services

    Intuitive Surgical's (ISRG) IoMT likely to benefit patients; market prospects impressive.

  • Better Buy: Intuitive Surgical, Inc. vs. Medtronic plc
    Motley Foolyesterday

    Better Buy: Intuitive Surgical, Inc. vs. Medtronic plc

    The robotic surgery kingpin versus a medical device titan: Which one is the better bet for new money today?

  • Is Medtronic Paying Too Much for Mazor Robotics?
    Motley Fool3 days ago

    Is Medtronic Paying Too Much for Mazor Robotics?

    This medical-device titan is paying up to swallow the robotic-surgery upstart whole. Does the deal make sense?

  • Here's Why You Should Buy Intuitive Surgical (ISRG) Now
    Zacks3 days ago

    Here's Why You Should Buy Intuitive Surgical (ISRG) Now

    Strength in the surgical platform and a string of developments make Intuitive Surgical (ISRG) a promising pick.

  • Medtronic to Buy Mazor Robotics for Robotic Spine Surgery
    Zacks3 days ago

    Medtronic to Buy Mazor Robotics for Robotic Spine Surgery

    The consolidation will combine Medtronic's (MDT) spine implants, navigation and intra-operative imaging technology with Mazor Robotics' robotic-assisted surgery (RAS) systems.

  • 3 MedTech Stocks for Safe Returns as Hurricane Fears Peak
    Zacks3 days ago

    3 MedTech Stocks for Safe Returns as Hurricane Fears Peak

    With the hurricane season at the peak, we bring three safe picks for investors.

  • Cerner's CommunityWorks Picked by Reeves County Hospital
    Zacks3 days ago

    Cerner's CommunityWorks Picked by Reeves County Hospital

    Cerner (CERN) sees a slew of developments in its EHR platform, market prospects bright.

  • Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now
    Zacks3 days ago

    Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

    Becton, Dickinson (BD) is likely to gain from expansion into emerging overseas markets.

  • InTouch Health to Build an Internet of Medical Things Network for Intuitive
    PR Newswire4 days ago

    InTouch Health to Build an Internet of Medical Things Network for Intuitive

    SANTA BARBARA, Calif., Sept. 20, 2018 /PRNewswire/ -- InTouch Health, the leading enterprise telehealth platform, today announced it has signed a multi-year licensing service agreement with Intuitive Surgical, Inc. (ISRG), the pioneer and a global technology leader in robotic-assisted, minimally invasive surgery. Under the agreement, the two companies will collaborate to deepen Intuitive's Internet of Medical Things (IoMT) network to connect into thousands of da Vinci surgical systems in medical institutions around the world on a single global network. InTouch Health's proprietary IoMT network will enable healthcare companies like Intuitive, to connect directly to their surgical systems worldwide to exchange real-time data for enhanced clinical insights, proactive service and maintenance monitoring, surgical collaboration between disparate locations, and the ability to extract data for data analytics and machine learning.

  • What Quest Diagnostics’ Valuation Trend Indicates
    Market Realist4 days ago

    What Quest Diagnostics’ Valuation Trend Indicates

    In September 2018, of the total 18 analysts covering Quest Diagnostics (DGX), ten analysts have given Quest stock a “buy” or higher rating, and eight analysts have given Quest a “hold” rating. The mean rating for Quest stock is 2.22 with a target price of $116.86 implying an upside potential of 9% over Quest’s closing price of $107.22 on September 18, 2018.

  • How Quest Diagnostics Is Positioned in 2018
    Market Realist5 days ago

    How Quest Diagnostics Is Positioned in 2018

    Quest Diagnostics (DGX) is a leading provider of diagnostic information services. Quest makes use of its database of clinical lab results to gain diagnostic insights that help to improve healthcare management. Quest’s diagnostics information services business (or DIS) provides data and insights based on routine, non-routine, and advanced clinical testing, as well as anatomic pathology testing and other diagnostic information services.

  • What’s the Upside Potential of Thermo Fisher Scientific Stock?
    Market Realist5 days ago

    What’s the Upside Potential of Thermo Fisher Scientific Stock?

    So far in 2018, Thermo Fisher Scientific (TMO) stock has generated double-digit returns for investors. Boosted by its strong financial performance, it’s risen from $192.98 on January 2 to its current level of $240 in September.

  • What Thermo Fisher Scientific’s Gross Margin Trend Indicates
    Market Realist5 days ago

    What Thermo Fisher Scientific’s Gross Margin Trend Indicates

    Thermo Fisher Scientific (TMO) is a leading provider of analytical instruments, equipment, reagents, and consumables. Thermo Fisher Scientific generated total revenue of $6.08 billion in the second quarter compared to $4.99 billion in the comparable period of 2017. Thermo Fisher generates revenue from product sales and services.

  • 7 ways to invest in the automation megatrend
    MarketWatch5 days ago

    7 ways to invest in the automation megatrend

    To hear some politicians tell it, unfair trade and labor practices have been killing American factory jobs and punishing the U.S. economy for years — and 2018 is finally the year we fight back. As Michael Hicks and Srikant Devaraj of Ball State noted in a research report entitled “The Myth and Reality of Manufacturing in America,” productivity in the sector has exploded in the last decade or two thanks to technological innovations, with automation chief among them. For example, if productivity had remained constant from the year 2000 to 2010, U.S. manufacturers would have employed 20.9 million workers in 2010 to achieve that year’s total output, rather than just 12.1 million.

  • Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now
    Zacks5 days ago

    Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now

    AngioDynamics (ANGO) to benefit from a solid product portfolio. However, the company???s core Peripheral Vascular business has been sluggish.

  • Veeva's Vault CDMS to Unify Clinical Data in Single Platform
    Zacks5 days ago

    Veeva's Vault CDMS to Unify Clinical Data in Single Platform

    Veeva's (VEEV) cloud-based applications' market prospects bright.

  • ResMed Unveils AirFit F30, Expands AirFit Mask Portfolio
    Zacks6 days ago

    ResMed Unveils AirFit F30, Expands AirFit Mask Portfolio

    ResMed's (RMD) recent product launches will strengthen its position in the high-potential sleep-disordered breathing market.

  • Zacks6 days ago

    QIAGEN (QGEN) Partners DiaSorin to Extend QuantFERON Offers

    Per QIAGEN (QGEN), the latest LIAISON QuantiFERON-TB Plus Test is likely to tackle the growing transformation of global latent TB testing market into the modern blood-based QuantiFERON technology.

  • Cooper's MiSight Lens Effective in Checking Juvenile Myopia
    Zacks6 days ago

    Cooper's MiSight Lens Effective in Checking Juvenile Myopia

    Cooper's (COO) core CVI business gets a boost from MiSight's positive study results.

  • Can Intuitive Surgical (ISRG) Keep the Earnings Surprise Streak Alive?
    Zacks6 days ago

    Can Intuitive Surgical (ISRG) Keep the Earnings Surprise Streak Alive?

    Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Here's Why You Should Add Abbott (ABT) to Your Portfolio Now
    Zacks6 days ago

    Here's Why You Should Add Abbott (ABT) to Your Portfolio Now

    Abbott (ABT) continues to deliver strong and consistent performance in all segments. The company has also been hogging the limelight within Diabetic Care on progress with its FreeStyle Libre.

  • CVS Health (CVS) PBM Strengthens, Aetna Deal Shows Promise
    Zacks7 days ago

    CVS Health (CVS) PBM Strengthens, Aetna Deal Shows Promise

    A robust 2019 PBM selling season is a tailwind for CVS Health (CVS). Additionally, the company's milestone acquisition of Aetna might alter the whole healthcare landscape in the United States.

  • QIAGEN Collaborates With NeuMoDx, Expands NGS Portfolio
    Zacks7 days ago

    QIAGEN Collaborates With NeuMoDx, Expands NGS Portfolio

    QIAGEN (QGEN) forges ahead with deals to strengthen the NGS Platform.

  • DaVita Kidney Care Opens 150000-Square-Foot Campus in DeLand
    Zacks7 days ago

    DaVita Kidney Care Opens 150000-Square-Foot Campus in DeLand

    DaVita's (DVA) dialysis care in the United States gets a boost; market prospects solid.

  • Pacific Biosciences (PACB) Up as VGP Picks Flagship Sequel
    Zacks10 days ago

    Pacific Biosciences (PACB) Up as VGP Picks Flagship Sequel

    Pacific Biosciences (PACB) sees a slew of developments in its coveted SMRT Sequel platform.